June 24, 2025 - 14:19

In a significant workforce reduction, UC San Diego Health has announced plans to lay off approximately 230 employees. This move represents around 1.5% of the organization's total staff, which exceeds 14,000 individuals. While the specific departments impacted by the layoffs have not yet been disclosed, the decision reflects ongoing challenges within the healthcare sector.
Officials have indicated that the layoffs are part of a broader strategy to streamline operations and address financial pressures. As healthcare institutions navigate a rapidly changing landscape, many are reevaluating their staffing needs to maintain efficiency and sustainability.
The announcement has raised concerns among employees and the community, as job losses can have a profound impact on both the individuals affected and the overall quality of care provided to patients. Stakeholders are awaiting further details regarding the affected positions and the potential implications for the health system as a whole.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....